AUA Guidelines: Salvage Therapy for Prostate Cancer

Host: Mark L. Gonzalgo, MD, PhD, MBA

Guest: Yaw Nyame, MD, MS, MBA

Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy. J Urol. 2024;211(4):509-517. https://www.auajournals.org/doi/10.1097/JU.0000000000003892

Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part II: treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy. J Urol. 2024;211(4):518-525. https://www.auajournals.org/doi/10.1097/JU.0000000000003891

Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part III: salvage therapy after radiotherapy or focal therapy, pelvic nodal recurrence and oligometastasis, and future directions. J Urol. 2024;211(4):526-532. https://www.auajournals.org/doi/10.1097/JU.0000000000003890

AUA Guidelines: Diagnosis and Management of Male Chronic Pelvic Pain

Host: Mark L. Gonzalgo, MD, PhD, MBA

Guests: Elise JB De, MD & Dane Johnson, MD

Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach. J Urol. 0(0). doi:10.1097/JU.0000000000004564. https://www.auajournals.org/doi/10.1097/JU.0000000000004564

Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Urol. 0(0). doi:10.1097/JU.0000000000004565. https://www.auajournals.org/doi/10.1097/JU.0000000000004565

Lai HH, Pontari MA, Argoff CE, at al. Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain. J Urol. 0(0). doi:10.1097/JU.0000000000004566. https://www.auajournals.org/doi/10.1097/JU.0000000000004566

NMIBC Treatment Landscape

Host: Mark L. Gonzalgo, MD, PhD, MBA

Guest: Janet Kukreja, MD, MPH, FACS

CME Available: auau.auanet.org/node/44076

ACKNOWLEDGEMENTS:

Support provided by independent educational grants from:

AstraZeneca

Johnson & Johnson

LEARNING OBJECTIVES:

At the conclusion of this activity, participants will be able to:

1. Select and implement immunotherapy regimens for patients with NMIBC in accordance with current AUA Guideline recommendations, tailoring treatment choices to tumor characteristics and individual patient needs.

2. Incorporate FDA-approved gene therapy options into NMIBC management by aligning therapeutic approaches with patient-specific factors, disease risk profile, and evolving clinical evidence.

3. Develop and integrate practical strategies to anticipate, monitor, and manage treatment-related side effects and immune-related adverse events in NMIBC, ensuring patient safety and treatment continuity.

MIBC Treatment Landscape

Host: Mark L. Gonzalgo, MD, PhD, MBA

Guest: Jen-Jane Liu, MD, FACS

CME Available: auau.auanet.org/node/44077

ACKNOWLEDGEMENTS:

Support provided by independent educational grants from:

AstraZeneca

Johnson & Johnson

LEARNING OBJECTIVES:

At the conclusion of this activity, participants will be able to:

1. Integrate immunotherapy and targeted therapy into the multimodal management of MIBC, selecting appropriate regimens and sequencing strategies based on current guidelines, clinical trial data, and patient-specific factors.

2. Evaluate the clinical role, mechanisms of action, and evidence base for targeted therapies in MIBC, including biomarker-driven selection to support personalized treatment planning.

3. Develop and apply practical approaches for preventing, monitoring, and managing immune-related adverse events and other toxicities associated with immunotherapy and targeted therapy to optimize patient safety, adherence, and quality of life.

AUA Guidelines: Genitourinary Syndrome of Menopause 

Host: Mark L. Gonzalgo, MD, PhD, MBA

Guests: Tracey S. Wilson, MD & Una J. Lee, MD

Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025)

Kaufman MR, Ackerman LA, Amin KA, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. J Urol. 0(0). doi:10.1097/JU.0000000000004589. https://www.auajournals.org/doi/10.1097/JU.0000000000004589

LG-IR-NMIBC Treatment Landscape

Host: Mark L. Gonzalgo, MD, PhD, MBA

Guest: Chad R. Ritch, MD, MBA, FACS

CME Available: auau.auanet.org/node/44036

ACKNOWLEDGEMENTS:

Support provided by independent educational grants from:

AstraZeneca

Johnson & Johnson

LEARNING OBJECTIVES:

At the conclusion of this activity, participants will be able to:

1. Differentiate between traditional and emerging intravesical therapies for LG-IR-NMIBC, considering mechanism of action, administration schedules, and patient eligibility to support individualized treatment planning.

2. Incorporate into practice shared decision-making strategies that align clinical recommendations with patient values, preferences, and quality-of-life considerations in the management of LG-IR-NMIBC.

3. Utilize practical approaches for integrating intravesical therapy into routine clinical workflows, including coordination among multidisciplinary teams, patient education, and follow-up to optimize adherence and outcomes.

Core Curriculum: Surgical Management of Urolithiasis

AUA Urology Core Curriculum: auau.auanet.org/core

Host: Mark L. Gonzalgo, MD, PhD, MBA

Guests: Marcelino E. Rivera, MD and T. Max Shelton, MD

Outline:

Segment 1: Acute Stone Event and Radiographic Evaluation

Segment 2: Shock Wave Lithotripsy

Segment 3: Ureteroscopy

Segment 4: Percutaneous Nephrolithotomy

Segment 5: Intracorporeal Lithotripsy

Segment 6: Special Considerations

AUA2025: Key Takeaways: BPH

Presenters: Bilal Chughtai, MD & Dean S. Elterman, MD, MSc, FRCSC

AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction

Presenters: George E. Koch, MD & Kurt A. McCammon, MD, FACS

AUA Guidelines: Recurrent Uncomplicated Urinary Tract Infections in Women

Host: Mark L. Gonzalgo, MD, PhD, MBA

Guests: A. Lenore Ackerman, MD, PhD & Melissa R. Kaufman, MD, PhD

Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025)

Ackerman AL, Bradley M, D’Anci KE, Hickling D, Kim SK, Kirkby E. Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025). J Urol. 0(0). doi: 10.1097/JU.0000000000004723